Pure Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain Silver Dihydrogen Citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. For more information, visit the company’s website at www.purebio.com.